维普期刊资源整合服务平台（V6.5）

37篇 您的检索式：作者名="Firsov AA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Antistaphylococcal effect related to the area under the curve/MIC ratio in an in vitro dynamic model: predicted breakpoints versus clinically achievable values for seven fluoroquinolones显示文摘	Firsov AA Lubenko IY Vostrov SN	2005	Antimicrob Agents Chemother2005，49，7：	1
2	Prevention ofthe selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model:an additive effect of the combinafion显示文摘	Firsov AA Voetrov SN Lubenko IY	2004	Int J Antimicrob Agents2004，23，：	1
3	In vitro pharmacodynamic evaluation of the mutant selection window hypothesis four fluoroquinolones against Staphylococcus aureus显示文摘	Firsov AA Vostrov SN Lubenko IY	2003	Antimicrob Agents Chemother2003，47，5：	1
4	AUC /MIC relationships to different endpoints of the antimicrobial effect 显示文摘	Firsov AA Zinner SH Vostrov SN	2002	J Antimicrob Chemother2002，50，4：	1
5	In vitro pharmacodynamic evalution of the mutant selection window hypothesis using for fluoroquinolones against Staphylococcs aureus显示文摘	Firsov AA Vostrov SN Lubenko IY	2003	Antimicrob Agents Chemother2003，47，：	1
6	Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model: an additive ef- fect of the combination 显示文摘	Firsov AA Vostrov SN Lubenko IY	2004	Int J Antimicrob Agents2004，23，5：	1
7	Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model:an additive effect of the combination显示文摘	Firsov AA Vostrov SN Lubenko IY	2004	Antimicrob Agents2004，23，：	1
8	Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion 显示文摘	Firsov AA Smirnova MV Strukova EN	2008	Int J Antimicrob Agents2008，32，5：	1
9	AUC/MIC relationships to different endpoints of the antimicrobial effect 显示文摘	Firsov AA Zinner SH Vostrov SN	2002	J Antimicrob Chemother2002，50，4：	1
10	Enrichment of fluoroquinolone-resistant Staphylococcus aureus: oscillating ciprofloxacin concentrations simulated at the upper and lower portions of the mutant selection window 显示文摘	Firsov AA Lubenko IY Smirnova MV	2008	Antimicrob Agents Chemother2008，52，6：	1
11	In vitro pharmacodynamic evaluation of the mutant selection window hypothesisusing four fluoroquinolones against staphylococcus aureus显示文摘	Firsov AA Vostrov SN Lubenko IY	2003	Antimicrob Agents Chemother2003，47，：	1
12	Invitro pharma codynarnic evaluation of the mutant selection window hypothesis: four fluoroquinolones against Staphylococcus aureus 显示文摘	Firsov AA Vostrov SN Lubenko IY	2003	Antimicrob Agents Chemother2003，47，5：	1
13	Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model:an additive effect of the combination显示文摘	Firsov AA Vostrov SN Lubenko IY	2004	Int J Antimicrob Agents2004，23，5：	1
14	In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against staphylococcus aureus显示文摘	Vostrov SN Lubenko IY	2003	Antimicrob Agents Chemother2003，47，：	1
15	Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycyeline in an in vitro dynamic model: an additive effect of the combination显示文摘	Firsov AA Vostrov SN Lubenko IY	2004	Antimierob Agents2004，23，：	1
16	Invitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus 显示文摘	Firsov AA Vostrov SN Lubenko IY etal	2003	AntimicrobAgents Chemother2003，47，5：	1
17	In vitro pharmacodynamie evalution of the mutant selection window by pothesis using for fluoroquinolones against Staphylococcs aureus 显示文摘	Firsov AA Vostrov SN Lubenko IY	2003	Antimicrob Agents Chemother2003，47，：	1
18	AUC/MIC relationships to different endpoints of the antimicrobial effect: multiple-dose in vitro simulations with moxifloxacin and tevofloxacin显示文摘	FIRSOV AA ZINNER SH VOSTROV SN	2002	J Antimicrob Chemother2002，50，10：	1
19	In vitro pharmacedynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against staphylococcus aureus显示文摘	Vostrov SN Lubenkob IY	2003	Antimicrob Agents Chemother2003，47，5：	1
20	Prevention of the selection of resistant staphylococcus aureus by moxifloxacin plus doxyeycline in an in vitro dynamic model:an additive effect of the combination显示文摘	Vostrov SN Lubenko IY	2004	Int J Antimicrob Agents2004，23，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示